← Back to Patent Explorer
US4522810A Expired / Lapsed US ⏱️ 0.0 years remaining

Feline calicivirus vaccine

Assignee: University of California
•
Filing: 1982-12-09
•
Granted: 1985-06-11
•
Expires: 2002-12-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Feline calicivirus FCV-2280 is used in a live, attenuated or killed form as a vaccine, either by itself or in combination with another feline calicivirus strain. The virus may be administered in an effective dosage in a variety of ways. The virus FCV-2280 has been deposited at the A.T.C.C. on Dec. 9, 1982, and given accession No. VR 2057.

Inventors

  • 👤 Niels C. Pedersen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 16:46
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/12; A61K39/125; A61K2039/51; A61K2039/525; A61K2039/5254; A61K2039/54; A61K2039/541; A61K2039/543; A61K2039/55; A61K2039/552; C; C12; C12N; C12N2770/00; C12N2770/00011; C12N2770/16011; C12N2770/16034; Y; Y10; Y10S; Y10S424/00; Y10S424/819

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 30 words
A vaccine for protection against viremia caused by feline calicivirus, said vaccine comprising the strain FCV-2280, in an effective amount to produce an immune response, and a physiologically acceptable carrier.
Claim 2
Dependent Claim 30 words
A vaccine for protection against viremia caused by feline calicivirus, said vaccine comprising the strain FCV-2280, in an effective amount to produce an immune response, and a physiologically acceptable carrier.
Claim 3
Dependent Claim 9 words
A vaccine according to claim 1 containing an adjuvant.
Claim 4
Dependent Claim 16 words
A vaccine according to any of claims 1 or 2, wherein said virus FCV-2280 is live.
Claim 5
Dependent Claim 16 words
A vaccine according to any of claims 1 or 2, wherein said virus FCV-2280 is attenuated.
Claim 6
Dependent Claim 16 words
A vaccine according to any of claims 1 or 2, wherein said virus FCV-2280 is inactivated.
Claim 7
Independent Claim 30 words
A method for protecting a cat from feline calicivirus infection which comprises: administering to said cat an effective dose of a vaccine according to any of claims 1 or 2.
Claim 8
Dependent Claim 11 words
A method according to claim 6, wherein said administering is oronasally.
Claim 9
Independent Claim 11 words
A method according to claiim 6, wherein said administering is subcutaneously.
Claim 10
Independent Claim 11 words
A method according to claiim 6, wherein said administering is subcutaneously.
Claim 11
Dependent Claim 11 words
A method according to claim 6, wherein said administering is intramuscular.
Claim 12
Dependent Claim 32 words
A vaccine according to any of claims 1 or 2 including at least one feline calicivirus strain selected from the group consisting of FCV-F9, FCV-LLK, FCV-M8, and FCV-255, in addition to FCV-2280.

References Cited (Backward Citations)

US3937812A Cited
US3944469A Cited
US4264587A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-06-10 1988-12-10 1989-06-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-06-10 1992-12-10 1993-06-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-06-10 1996-12-10 1997-06-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag